Aarkstore Enterprise - Womens Infertility - Pipeline Assessment and Market Forecasts to 2017

Aarkstore announce a new report "Womens Infertility - Pipeline Assessment and Market

Forecasts to 2017" through its vast collection of market research report.

Summary

The industry analysis specialist, has released its new report, "Women's Infertility - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global women's infertility therapeutics market. The report identifies the key trends shaping and driving the global women's infertility therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global women's infertility sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Estimates that the global women's infertility market was valued at $1,417m in 2009 and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 2% to reach $1,609m by 2017. The slow market growth is attributed to the patent expiry of the branded products such as Cetrotide and Ovidrel in 2015. Some key branded products, such as Cetrotide, GONAL-f, Crinone, Ovidrel, Luveris, Pergoveris and Puregon, are going to face a severe threat from generics as they approach patent expiry between 2010 and 2015

Scope

The scope of the report includes:

- Annualized global women's infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.

- Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include Gonadotropin-Releasing hormone (GnRH) antagonists, AMP-activated protein kinase (AMPK) agonists, GnRH agonists, Recombinant human chorionic gonatropin, Follicle stimulating hormone, Selective Estrogen Receptor Modulators (SERMs) and aromatase inhibitor.

- Analysis of the current and future market competition in the global women's infertility therapeutics market. The key future market players covered are Ferring Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd. and PregLem SA and Merck.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the women's infertility market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.

- Develop business strategies by understanding the trends shaping and driving the global women's infertility therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global women's infertility therapeutics market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.

- What's the next big thing in the global women's infertility therapeutics market landscape? Identify, understand and capitalize.

For more information, please visit:

http://www.aarkstore.com/reports/Womens-Infertility-Pipeline-Assessment-and-Market-Forecasts-to-2017-39937.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise - Womens Infertility - Pipeline Assessment and Market Forecasts to 2017

By: Pushpanjali

POST COMMENT

EMEA Logistics and Express Market Overview - Market Research Report On Aarkstore Enterprise Stock Market and Painful Investment in Nepal Aarkstore enterprise-- Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 The Basics of Email Marketing Airlines: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide Aarkstore enterprise--- Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 Profits for everyone from Forex market… 2 Basic Tips To Avoid an Investment Scam My Shed Plans Scam 5 Things To know Not To Trap in an Investment Scam Get More Money Profit from Nifty Option Tips Do You Need a Social Media Marketing Plan? Top Social Media Marketing Tips the Big Shots are Doing that You can Try